SANTA CLARA, Calif., Jan. 29 /PRNewswire-FirstCall/ --
Applied Imaging Corp. (Nasdaq: AICX) announced today that it has achieved its
fourth consecutive quarter of record revenues. Preliminary sales for the
fourth quarter of $5.25 million were 13% ahead of last year's fourth quarter
sales of $4.65 million. The Company also achieved record sales of $0.5
million in the quarter with its MDS(TM) genetic testing systems.
"We are very pleased by the company's continued strong sales performance,
in spite of a weak economic environment in major markets," commented Carl
Hull, Applied Imaging CEO. "Revenues from our MDS system set a new record in
the fourth quarter, reflecting growing market demand for our unique gene probe
imaging capabilities. Additionally, 2001 was the first calendar year in our
history where sales increased sequentially each quarter, demonstrating
well-established sales momentum for both existing and new products."
Applied Imaging management will discuss fourth quarter performance in
detail during the Company's quarterly conference call scheduled for February
20 at 11:00 a.m. (EST).
About Applied Imaging
Applied Imaging Corp., based in Santa Clara, California, is the leading
supplier of automated imaging systems utilized in genetics and pathology
laboratories for the analysis of chromosomes in cancer and prenatal disorders.
The Company markets a range of clinical and research imaging systems for
fluorescence and brightfield microscopy applications, including the Company's
MDS(TM), CytoVision(R), PowerGene(R) and QUIPS(R) product lines. Applied
Imaging has installed in excess of 2,500 systems in over 1,000 laboratories in
more than 35 countries.
This press release contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995, regarding, among other
matters, the Company's current and future financial performance, preliminary
sales estimates and the sales performance of the MDS system. Forward-looking
statements address matters that are subject to a number of risks,
uncertainties and other factors that could cause actual results to differ
materially, as discussed in the Company's filings with the Securities and
Exchange Commission, including the form 10-K for the year ended December 31,
2000.
For additional information on Applied Imaging via fax, please dial
1-800-PRO-INFO, (732-544-2850 outside of the U.S.), code AICX, or visit the
Company's web site at http://www.aicorp.com .
SOURCE Applied Imaging Corp.
 back to top
Related links:
http://www.aicorp.com
CONTACT:
Barry Hotchkies, CFO of Applied Imaging
Corp., +1-408-562-0250; or Liz Saghi (Investor/Media) or Pam
Roberts (General), both of FRB/Weber Shandwick, +1-415-986-1591,
for Applied Imaging Corp.
|
